Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
DKFZ together with Technical University of Denmark (DTU) developed an analogue of Griseofulvin as a compound for cancer treatment, which selectively targets cancer cells only.
Griseofulvin is a natural antibiotic produced by Penicillium griseofulvum as well as other microfungi and is still commonly used in humans for the treatment of dermatomycoses of skin, hair, and nails caused by Microsporum, Trichophyton, and Epidermophyton. Further hit to lead development of the natural compound was achieved by medicinal chemistry with corresponding biological activity tests. Advantages – drug which selectively targets cancer cells only with little effect on normal tissues – possible treatment of several cancer types – analogue of natural compound (griseofulvin, orally available, almost no side effects in humans), thoroughly studied in biological tests
Further Information: PDF
Deutsches Krebsforschungszentrum DKFZ
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Properties of new materials for microchips
… can now be measured well. Reseachers of Delft University of Technology demonstrated measuring performance properties of ultrathin silicon membranes. Making ever smaller and more powerful chips requires new ultrathin…
Floating solar’s potential
… to support sustainable development by addressing climate, water, and energy goals holistically. A new study published this week in Nature Energy raises the potential for floating solar photovoltaics (FPV)…
Skyrmions move at record speeds
… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…